• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对膳食补充剂监管的理解。

Patients' understanding of the regulation of dietary supplements.

作者信息

Ashar Bimal H, Miller Redonda G, Pichard Carmen P, Levine Rachel, Wright Scott M

机构信息

Division of General Internal Medicine, Johns Hopkins University, 601 N. Caroline Street, #7143, Baltimore, MD 21287, USA.

出版信息

J Community Health. 2008 Feb;33(1):22-30. doi: 10.1007/s10900-007-9063-7.

DOI:10.1007/s10900-007-9063-7
PMID:18080205
Abstract

The Dietary Supplement Health and Education Act (DSHEA) permits manufacturers to sell products without providing pre-market evidence of safety or efficacy. One fundamental reason for the passage of the DSHEA was to empower consumers to make their own choices, free from governmental restriction. Yet, little is known about the public's understanding of the supplement regulatory process. We undertook a study to assess patients' knowledge regarding governmental oversight of product marketing and advertising. A survey of 300 adult patients from the Baltimore Metropolitan area was administered after showing participants an advertisement for a dietary supplement. Patients were asked questions regarding their understanding of federal regulation of the advertised product. A total of 52% of respondents were unaware that the dietary supplement had not been approved by the government while 63% were unaware that the advertisement for that supplement had not been pre-approved. Factors associated with a lack of understanding of the product approval process included lower education level (OR 2.52; 95% CI 1.52-4.19) and non-Caucasian race (OR 1.99; 95% CI 1.17-3.36). Lower education level was also associated with confusion regarding the advertisement approval process (OR 2.60; 95% CI 1.48-4.57). Based on these results, patients seem unclear about the government's role in the regulation of dietary supplements. Educational efforts should be geared towards clarifying these issues.

摘要

《膳食补充剂健康与教育法》(DSHEA)允许制造商在不提供上市前安全性或有效性证据的情况下销售产品。DSHEA得以通过的一个根本原因是赋予消费者自主选择权,使其免受政府限制。然而,对于公众对补充剂监管过程的理解却知之甚少。我们开展了一项研究,以评估患者对政府对产品营销和广告监管的了解情况。在向参与者展示一则膳食补充剂广告后,对来自巴尔的摩都会区的300名成年患者进行了调查。询问患者对所宣传产品的联邦监管的理解相关问题。共有52%的受访者不知道该膳食补充剂未获政府批准,而63%的人不知道该补充剂的广告未预先获批。与对产品批准过程缺乏理解相关的因素包括教育水平较低(比值比2.52;95%置信区间1.52 - 4.19)和非白种人种族(比值比1.99;95%置信区间1.17 - 3.36)。教育水平较低还与对广告批准过程的困惑有关(比值比2.60;95%置信区间1.48 - 4.57)。基于这些结果,患者似乎不清楚政府在膳食补充剂监管中的作用。应开展教育工作以澄清这些问题。

相似文献

1
Patients' understanding of the regulation of dietary supplements.患者对膳食补充剂监管的理解。
J Community Health. 2008 Feb;33(1):22-30. doi: 10.1007/s10900-007-9063-7.
2
Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.膳食补充剂健康与教育法案对消费者关于膳食补充剂安全性和有效性的信念的影响。
J Health Commun. 2011 Mar;16(3):230-44. doi: 10.1080/10810730.2010.529493.
3
Consumers' perceptions of the dietary supplement health and education act: implications and recommendations.消费者对《膳食补充剂健康与教育法》的认知:影响与建议。
Drug Test Anal. 2016 Mar-Apr;8(3-4):407-9. doi: 10.1002/dta.1857. Epub 2015 Nov 2.
4
Physicians' understanding of the regulation of dietary supplements.医生对膳食补充剂监管的理解。
Arch Intern Med. 2007 May 14;167(9):966-9. doi: 10.1001/archinte.167.9.966.
5
Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.麻黄:昨天、《膳食补充剂健康与教育法》以及明天——对1994年《膳食补充剂健康与教育法》的十年展望
J Herb Pharmacother. 2005;5(3):67-86.
6
What is the research base for the use of dietary supplements?使用膳食补充剂的研究依据是什么?
Public Health Nutr. 1999 Mar;2(1):35-8. doi: 10.1017/s136898009900004x.
7
Patient use of dietary supplements: a clinician's perspective.患者对膳食补充剂的使用:临床医生的视角
Curr Med Res Opin. 2008 Apr;24(4):1209-16. doi: 10.1185/030079908x280743. Epub 2008 Mar 17.
8
Dietary supplements: What's in a name? What's in the bottle?膳食补充剂:名称里有什么?瓶子里有什么?
Drug Test Anal. 2016 Mar-Apr;8(3-4):410-2. doi: 10.1002/dta.1855. Epub 2015 Nov 2.
9
Americans' views on the use and regulation of dietary supplements.美国人对膳食补充剂的使用及监管的看法。
Arch Intern Med. 2001 Mar 26;161(6):805-10. doi: 10.1001/archinte.161.6.805.
10
Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults.草药产品和膳食补充剂:老年人使用情况、态度及知识的调查
J Am Osteopath Assoc. 2007 Jan;107(1):13-20; quiz 21-3.

引用本文的文献

1
False and misleading health-related claims in food supplements on Spanish radio: an analysis from a European Regulatory Framework.食品补充剂在西班牙广播中的虚假和误导性与健康相关的声明:基于欧洲监管框架的分析。
Public Health Nutr. 2021 Oct;24(15):5156-5165. doi: 10.1017/S1368980021002007. Epub 2021 May 11.
2
The Basis of Structure/Function Claims of Nutraceuticals.营养保健品结构/功能宣称的依据。
Clin Rev Allergy Immunol. 2016 Dec;51(3):370-382. doi: 10.1007/s12016-016-8536-9.
3
Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study.

本文引用的文献

1
Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.美国成年人使用膳食补充剂情况:来自1999 - 2000年国家健康与营养检查调查的数据。
Am J Epidemiol. 2004 Aug 15;160(4):339-49. doi: 10.1093/aje/kwh207.
2
Use of complementary and alternative medicines by ambulatory patients.门诊患者使用补充和替代药物的情况。
Arch Intern Med. 2004 May 10;164(9):1004-9. doi: 10.1001/archinte.164.9.1004.
3
Internet marketing of herbal products.草药产品的网络营销。
双相障碍患者常用膳食补充剂:一项自然主义、自我报告研究。
Int J Bipolar Disord. 2015 Dec;3(1):29. doi: 10.1186/s40345-015-0029-x. Epub 2015 Jun 2.
4
Provider and patient expectations for dietary supplement discussions.提供者和患者对膳食补充剂讨论的期望。
J Gen Intern Med. 2014 Sep;29(9):1242-9. doi: 10.1007/s11606-014-2899-5. Epub 2014 May 30.
5
Confidence in the efficacy and safety of dietary supplements among United States active duty army personnel.美国现役军人对膳食补充剂功效和安全性的信心。
BMC Complement Altern Med. 2012 Oct 10;12:182. doi: 10.1186/1472-6882-12-182.
6
Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research.性别、药物和性别角色:绘制药品政策研究中基于性别的分析方法的应用图谱。
Int J Equity Health. 2010 Nov 19;9:26. doi: 10.1186/1475-9276-9-26.
JAMA. 2003 Sep 17;290(11):1505-9. doi: 10.1001/jama.290.11.1505.
4
A critical evaluation of Internet marketing of products that contain ephedra.对含麻黄碱产品网络营销的批判性评估。
Mayo Clin Proc. 2003 Aug;78(8):944-6. doi: 10.4065/78.8.944.
5
Tighter regulation needed for dietary supplements in USA.
Lancet. 2003 May 3;361(9368):1566. doi: 10.1016/S0140-6736(03)13207-2.
6
The need for regulation of dietary supplements--lessons from ephedra.膳食补充剂监管的必要性——麻黄的教训
JAMA. 2003 Mar 26;289(12):1568-70. doi: 10.1001/jama.289.12.1568. Epub 2003 Mar 10.
7
The relative safety of ephedra compared with other herbal products.麻黄与其他草药产品相比的相对安全性。
Ann Intern Med. 2003 Mar 18;138(6):468-71. doi: 10.7326/0003-4819-138-6-200303180-00010.
8
Adverse events associated with dietary supplements: an observational study.与膳食补充剂相关的不良事件:一项观察性研究。
Lancet. 2003 Jan 11;361(9352):101-6. doi: 10.1016/S0140-6736(03)12227-1.
9
Balancing safety of dietary supplements with the free market.平衡膳食补充剂的安全性与自由市场
Ann Intern Med. 2002 Apr 16;136(8):616-8. doi: 10.7326/0003-4819-136-8-200204160-00011.
10
Severe hepatotoxicity associated with the dietary supplement LipoKinetix.与膳食补充剂LipoKinetix相关的严重肝毒性。
Ann Intern Med. 2002 Apr 16;136(8):590-5. doi: 10.7326/0003-4819-136-8-200204160-00008.